Paramethadione
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | D (US) |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | Not significant |
| Identifiers | |
| CAS number | 115-67-3 |
| ATC code | N03AC01 |
| PubChem | CID 8280 |
| DrugBank | APRD00236 |
| ChemSpider | 7979 |
| UNII | Z615FRW64N |
| KEGG | D00495 |
| ChEMBL | CHEMBL1100 |
| Chemical data | |
| Formula | C7H11NO3 |
| Mol. mass | 157.167 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.[1]
[edit] Chemistry
Paramethadione, 5-ethyl-3,5-dimethyloxazolidine-2,4-dione, differs from trimethadione only in the substitution of one methyl group with an ethyl group. It is synthesized in a completely analogous manner, except that it comes from 2-hydroxy-2-methylbutyric acid instead of 2-hydroxyisobutyric acid.
- M.A. Spielman, U.S. Patent 2,575,693 (1951).
[edit] References
- ^ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007.
[edit] External links
- DDB 33106
- Hoffman, D; Chun A (1975). "Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose". J Pharm Sci 64 (10): 1702–1703. doi:10.1002/jps.2600641027. PMID 1185541.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |